Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression

28 Feb 2022

Abstract excerpt

Receptors are macromolecules that transmit information regulating cell proliferation, differentiation, migration and apoptosis, play key roles in oncogenic processes and correlate with the prognoses of cancer patients. Thus, targeting receptors to constrain cancer development and progression has gained widespread interest. Small molecule compounds of natural origin have been widely used as drugs or adjuvant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioactive Compounds and Antitumor Agents
Share to Flavonoids in Medical Research
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35269825
DOI: 10.3390/ijms23052672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and ProgressionPMID 35269825Read ↗

Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.Semantic proximity Read ↗

Delineating the role of nuclear receptors in colorectal cancer, a focused reviewSemantic proximity Read ↗

Receptor tyrosine kinases: biological functions and anticancer targeted therapySemantic proximity Read ↗

Receptors as drug targets.Semantic proximity Read ↗

Receptor tyrosine kinases as targets for anticancer drugs.Semantic proximity Read ↗

Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approachesSemantic proximity Read ↗

Targeting rapid action of sex steroid receptors in breast and prostate cancersSemantic proximity Read ↗

GPCR Inhibition in Treating LymphomaSemantic proximity Read ↗

Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic ResponseSemantic proximity Read ↗

To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting InhibitorsSemantic proximity Read ↗

Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of ActionSemantic proximity Read ↗

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and ChallengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.